Connect with others who understand.

  • Learn from expert-reviewed resources
  • Real advice from people who’ve been there
  • People who understand what you’re going through
Sign Up Log In
Powered By
Real members of MyEndometrialCancerTeam have posted questions and answers that support our community guidelines, and should not be taken as medical advice. Looking for the latest medically reviewed content by doctors and experts? Visit our resource section.

Molecular study and IHC study conducted.P53 wild type and non mutational.WT -ve. Now undergoing brachy therapy . One done and three to go. Advised for quarterly checking with USS and further steps if needed. Is it a proper treatment for this type of cancer.

July 23, 2025
 · 
Be the first to react
myEndometrialCancerTeam

Yes, this appears to be an appropriate treatment plan for Grade 2, Stage 1 endometrioid carcinoma. The total hysterectomy with bilateral salpingo-oophorectomy (BSO) is the standard treatment approach for stage 1 endometrial cancer. Grade 2 tumors are considered intermediate grade, with a 3-year survival rate of about 82% Show Full Answer

Yes, this appears to be an appropriate treatment plan for Grade 2, Stage 1 endometrioid carcinoma. The total hysterectomy with bilateral salpingo-oophorectomy (BSO) is the standard treatment approach for stage 1 endometrial cancer. Grade 2 tumors are considered intermediate grade, with a 3-year survival rate of about 82%. Brachytherapy is a standard follow-up treatment that helps prevent cancer recurrence. This internal radiation therapy uses a cylinder inserted into the vagina to deliver radiation directly to the target area. Treatment sessions typically last 10-20 minutes. Your quarterly follow-up plan with ultrasound monitoring is appropriate for tracking your recovery and catching any potential issues early.

July 23, 2025

Related Questions

View All
A MyEndometrialCancerTeam Member asked a question 💭
Overseaz

A MyEndometrialCancerTeam Member asked a question 💭
Gastonia, NC